Automated Breast Ultrasound System Could Revolutionize Breast Cancer Research

Share Article

Ultrasonix system captures 360 degree views in two to four minutes

Automated breast ultrasound system

SonixEmbrace automated breast ultrasound system captures realistic, uncompressed images of a breast in two to four minutes.

With the current focus on using ultrasound for cancer detection in dense breasts, we believe this system will be particularly well received by researchers who can benefit from easy access to gigabytes of raw data that can be easily manipulated.

Ultrasonix is putting the final touches on an ultrasound system that automatically captures high resolution images of a full breast in two to four minutes. Compared to traditional freehand ultrasound systems, the SonixEmbrace system is at least five times faster and less prone to imaging variations caused by differences in scanning methods. Ultrasonix will demonstrate the system for the first time at the American Association of Cancer Research (AACR) 2012 conference in Chicago from April 1-4.

SonixEmbrace uses a patented 360 degree rotating concave ultrasound transducer design to capture realistic, uncompressed images of a breast, while the patient lies face down in a comfortable position. Integrated with the Ultrasonix Research platform from Ultrasonix, the system also captures gigabytes of raw data, which is ideal for research on cancer detection and treatment monitoring and can be used in conjunction with reconstructed B-Mode ultrasound planes.

“We’re excited about being able to show a product that can revolutionize breast cancer research at our first AACR conference,” said Kris Dickie, director of research and OEM at Ultrasonix. “With the current focus on using ultrasound for cancer detection in dense breasts, we believe this system will be particularly well received by researchers who can benefit from easy access to gigabytes of raw data that can be easily manipulated.”

In addition to cancer detection, researchers are currently using ultrasound to monitor the success of treatment on cancer patients. The Ultrasonix research platform supports the novel technique of monitoring cell death, which allows researchers to determine the success of treatment within as little as one to four weeks.

Data from the SonixEmbrace Research can also be integrated with Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) to provide a more complete picture of the breast. The system is currently available for Research purposes only.

Ultrasonix will also showcase its preclinical research platform, which has dedicated applications and presets for small animal imaging, access to online imaging guides and the ability to record a full exam for reference and training purposes. The platform’s ability to image at both high and low frequencies allows for easy translation of research from preclinical to clinical studies on the same platform.

“Our roots are in the research community and 50% of ultrasound research papers that are published are based on work done on our systems,” Kris adds. “We’re looking forward to increasing our presence in the pre-clinical and clinical research world. I believe we’re one of the few companies whose systems bridge the gap between research on animals and people.”

About Ultrasonix
Ultrasonix develops and manufactures diagnostic ultrasound imaging systems with customizable touch screens to simplify workflows. The company's systems are built on an open software platform that enables remote service and easy updates to keep current with advancements in imaging technology. Founded in 2000, Ultrasonix is a privately-held company headquartered in Richmond, British Columbia, Canada. http://www.ultrasonix.com/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Neena Rahemtulla
Visit website